IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Loncar Cancer Immunotherapy (CNCRUSD)

CUSIP: 26922A826 | XB | 83 institutional holders

Quarters

Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2025

Osaic Holdings, Inc.150
0.0% of portfolio›$2.2K
StyleTurnoverLocationFiled
Osaic Holdings, Inc.
150$2.2K0.0%IndexLowScottsdale, AZ2025-09-04